Medizinische Universitat Innsbruck — Innsbruck

Public research footprint of Medizinische Universitat Innsbruck, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Non-small Cell Lung Cancer · Metastatic HER2-positive Breast Cancer · Locally Advanced Renal Cell Carcinoma · Symptomatic Neurogenic Orthostatic Hypotension

Recently updated registry entries

NCT07623161 — A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… (Recruiting)
NCT06319820 — A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in… (Recruiting)
NCT06819007 — Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Medizinische Universitat Innsbruck?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.